基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Objective:To explore potential natural products against severe acute respiratory syndrome coronavirus(SARS-CoV-2)via the study of structural and non-structural proteins of human coronaviruses.Methods:In this study,we performed an in-silico survey of 25 potential natural compounds acting against SARS-CoV-2.Molecular docking studies were carried out using compounds against 3-chymotrypsin-like protease(3CLPRO),papain-like protease(PLPRO),RNA-dependent RNA polymerase(RdRp),non-structural protein(nsp),human angiotensin converting enzyme 2 receptor(hACE2R),spike glycoprotein(S protein),abelson murine leukemia viral oncogene homolog 1(ABL1),calcineurin-nuclear factor of activated T-cells(NFAT)and transmembrane protease serine 2.Results:Among the screened compounds,amentoflavone showed the best binding affinity with the 3CLPRO,RdRp,nsp13,nsp15,hACE2R,ABL1 and calcineurin-NFAT;berbamine with hACE2R and ABL1;cepharanthine with nsp10,nsp14,nsp16,S protein and ABL1;glucogallin with nsp15;and papyriflavonol A with PLPRO protein.Other good interacting compounds were juglanin,betulinic acid,betulonic acid,broussooflavan A,tomentin A,B and E,7-methoxycryptopleurine,aloe emodin,quercetin,tanshinone I,tylophorine and furruginol,which also showed excellent binding affinity towards a number of target proteins.Most of these compounds showed better binding affinities towards the target proteins than the standard drugs used in this study.Conclusion:Natural products or their derivatives may be one of the potential targets to fight against SARS-CoV-2.
推荐文章
SARS-CoV-2变异株的遗传学特征和致病特点
SARS病毒
遗传变异
突变
毒力
新型冠状病毒
奥密克戎
合理防治SARS-CoV-2感染的思考
传染病
感染病
COVID-19
预防
治疗
合理
新型冠状病毒SARS-CoV-2感染治疗中的“老药新用”
新型冠状病毒
SARS-CoV-2
抗病毒药物
临床药物
老药新用
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
来源期刊 中国结合医学杂志(英文版) 学科
关键词
年,卷(期) 2022,(3) 所属期刊栏目 Original Articles
研究方向 页码范围 249-256
页数 8页 分类号
字数 语种 英文
DOI 10.1007/s11655-021-3504-5
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2022(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
引文网络交叉学科
相关学者/机构
期刊影响力
中国结合医学杂志(英文版)
月刊
1672-0415
11-4928/R
大16开
北京西苑操场1号
82-825
1995
eng
出版文献量(篇)
2643
总下载数(次)
0
论文1v1指导